Northcoast Research Weighs in on Cooper Companies Inc’s FY2019 Earnings (COO)

Share on StockTwits

Cooper Companies Inc (NYSE:COO) – Equities research analysts at Northcoast Research raised their FY2019 earnings estimates for Cooper Companies in a research report issued on Wednesday, March 6th. Northcoast Research analyst D. Keiser now forecasts that the medical device company will post earnings of $12.07 per share for the year, up from their prior estimate of $11.71. Northcoast Research also issued estimates for Cooper Companies’ Q4 2019 earnings at $3.17 EPS and Q4 2020 earnings at $3.60 EPS.

A number of other analysts have also issued reports on the stock. Wells Fargo & Co lifted their price objective on shares of Cooper Companies from $290.00 to $295.00 and gave the company an “outperform” rating in a research note on Monday, November 12th. Goldman Sachs Group lowered shares of Cooper Companies from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $233.00 to $221.00 in a research note on Friday, January 4th. William Blair reiterated an “outperform” rating on shares of Cooper Companies in a research note on Saturday, January 12th. KeyCorp restated a “buy” rating on shares of Cooper Companies in a research note on Sunday, December 9th. Finally, Oppenheimer set a $282.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a research note on Friday, December 7th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $304.70.

COO opened at $282.76 on Thursday. The company has a market cap of $14.44 billion, a PE ratio of 24.59, a PEG ratio of 2.30 and a beta of 0.88. Cooper Companies has a 52-week low of $216.47 and a 52-week high of $299.00. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.16 and a current ratio of 2.03.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Tuesday, March 5th. The medical device company reported $2.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.38. Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%.

The business also recently declared a semiannual dividend, which was paid on Friday, February 8th. Investors of record on Tuesday, January 22nd were paid a $0.03 dividend. The ex-dividend date was Friday, January 18th. This represents a dividend yield of 0.02%. Cooper Companies’s dividend payout ratio (DPR) is presently 0.52%.

In other Cooper Companies news, Director Allan E. Rubenstein bought 348 shares of the stock in a transaction on Monday, December 10th. The stock was purchased at an average price of $241.59 per share, for a total transaction of $84,073.32. Following the completion of the purchase, the director now directly owns 4,524 shares in the company, valued at $1,092,953.16. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by insiders.

Hedge funds have recently added to or reduced their stakes in the business. Dupont Capital Management Corp boosted its holdings in shares of Cooper Companies by 4.4% during the fourth quarter. Dupont Capital Management Corp now owns 881 shares of the medical device company’s stock valued at $224,000 after acquiring an additional 37 shares during the period. Thrivent Financial for Lutherans boosted its holdings in shares of Cooper Companies by 1.8% during the fourth quarter. Thrivent Financial for Lutherans now owns 2,141 shares of the medical device company’s stock valued at $545,000 after acquiring an additional 37 shares during the period. Oregon Public Employees Retirement Fund boosted its holdings in shares of Cooper Companies by 0.8% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 5,360 shares of the medical device company’s stock valued at $1,364,000 after acquiring an additional 41 shares during the period. Raymond James Trust N.A. boosted its holdings in shares of Cooper Companies by 5.4% during the fourth quarter. Raymond James Trust N.A. now owns 814 shares of the medical device company’s stock valued at $207,000 after acquiring an additional 42 shares during the period. Finally, Rehmann Capital Advisory Group boosted its holdings in shares of Cooper Companies by 24.3% during the fourth quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock valued at $56,000 after acquiring an additional 43 shares during the period.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Further Reading: Market Capitalization in the Stock Market

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

LPL Financial  Cut to Hold at BidaskClub
LPL Financial Cut to Hold at BidaskClub
KEYW  Rating Increased to Buy at BidaskClub
KEYW Rating Increased to Buy at BidaskClub
IAC/InterActiveCorp  Raised to Buy at BidaskClub
IAC/InterActiveCorp Raised to Buy at BidaskClub
Reviewing Guardant Health  & Its Competitors
Reviewing Guardant Health & Its Competitors
Head to Head Comparison: Red Lion Hotels  & Its Rivals
Head to Head Comparison: Red Lion Hotels & Its Rivals
$480.90 Million in Sales Expected for Kraton Corp  This Quarter
$480.90 Million in Sales Expected for Kraton Corp This Quarter


© 2006-2019 Ticker Report